Pharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteers

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 35, Issue 3-4, 2011, Pages 83-87

  Vlase, Laurian ^a   Popa, Adina ^a   Neag, Maria ^a   Muntean, Dana ^a   Leucuţa, Sorin E ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Ciprofloxacin; Drug interaction; Pharmacokinetics; Zolpidem

Indexed keywords

CIPROFLOXACIN; CIPROLEN; SANVAL; UNCLASSIFIED DRUG; ZOLPIDEM;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG POTENTIATION; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MORNING DOSAGE; NORMAL HUMAN; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CIPROFLOXACIN; DRUG INTERACTIONS; HALF-LIFE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PYRIDINES; YOUNG ADULT;

EID: 79953804041     PISSN: 03787966     EISSN: 21070180     Source Type: Journal    
DOI: 10.1007/s13318-010-0014-9     Document Type: Article

References (15)

1. Abou-Auda HS, Mustafa AA, Al-Humayyd MS (2008) Pharmacokinetic interaction of ketoconazole and itraconazole with ciprofloxacin. Biopharm Drug Dispos 29(1):29-35 (Pubitemid 351265896)
2. Cysneiros RM, Farkas D, Harmatz JS, Von Moltke LL, Greenblatt DJ (2007) Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Clin Pharmacol Ther 82(1):54-62. doi:10.1038/sj.clpt.6100211 (Pubitemid 46944198)
3. Farkas D, Volak LP, Harmatz JS, Von Moltke LL, Court MH, Greenblatt DJ (2009) Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem. Clin Pharmacol Ther 85(6):644-650. doi:10.1038/clpt.2008.293
4. Herrlin K, Segerdahl M, Gustafsson LL, Kalso E (2000) Methadone, ciprofloxacin and adverse drug reactions. Lancet 356(9247): 2069-2070 (Pubitemid 32009827)
5. Iqbal Z, Khan A, Naz A, Khan JA, Khan GS (2009) Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single-dose, twoperiod crossover study in healthy adult volunteers. Clin Drug Investig 29(4):275-281
6. Lamba JK, Lin YS, Schuetz EG, Thummel KE (2002) Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev 54:1271-1294. doi:10.1016/S0169-409X(02)00066-2 (Pubitemid 35284253)
7. Neve EPA, Ingelman-Sundberg M (2010) Cytochrome P450 proteins: retention and distribution from the endoplasmic reticulum. Curr Opin Drug Discov Devel 13(1):78-85
8. Saari TI, Laine K, Leino K, Valtonen M, Neuvonen PJ, Olkkola KT (2006) Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects. Br J Clin Pharmacol 63(1):116-120. doi:10.1111/j.1365-2125. 2006.02707.x
9. Salvà P, Costa J (1995) Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet 29(3):142-153
10. Schuirmann DJ (1987) A comparison of the 2 one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 15:657-680
11. Swainston HT, Keatin GM (2005) Zolpidem: a review of its use in the management of insomnia. CNS Drugs 19(1):65-89
12. The European Agency for the Evaluation of Medicinal Products, Committee for medicinal products for human use (2010) Guideline on the investigation of bioequivalence. http://www.ema.europa.eu/pdfs/human/qwp/140198enrev1fin.pdf. Accessed 31 May 2010
13. U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (2002) Guidance for Industry. Bioavailability and Bioequivalence studies for orally administered drug products-general considerations. http://www.fda.gov/downloads/Drugs/ GuidanceCompliance-RegulatoryInformation/Guidances/ucm070124.pdf. Accessed 31 May 2010
14. Villikka K, Kivistö KT, Luurila H, Neuvonen PJ (1997) Rifampin reduces plasmaconcentrations and effects of zolpidem. Clin Pharmacol Ther 62(6):629-634. doi:10.1016/S0009-9236(97)90082-5 (Pubitemid 28068066)
15. Von Moltke LL, Greenblatt DJ, Granda BW, Duan SX, Grassi JM, Venkatakrishnan K (1999) Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. Br J Clin Pharmacol 48:89-97. doi:10.1046/j.1365-2125.1999.00953.x (Pubitemid 29296668)